Dr. Amal is an Assistant Professor in the Institute for Drug Research, School of Pharmacy, Faculty of Medicine at the Hebrew University of Jerusalem. His lab studies neurological disorders such as the autism spectrum and Alzheimer's disease using advanced omics technologies combined with bioinformatics, pharmacological, biochemical, biological, and behavioral methods. Specifically, Dr. Amal's lab is interested in the role of nitric oxide and S-nitrosylation in these disorders. Ultimately, Dr. Amal aspires to understand these diseases’ molecular mechanisms, detect early biomarkers, and discover novel therapeutic strategies.
Dr. Amal combines analytical chemistry, big data analysis, and nano-sensors technology to understand the biochemical pathways of volatile organic compounds (VOCs) emitted from pathological cells. Deciphering the chemical fingerprint may enable the diagnosis of various diseases via exhaled breath alone.
In the News
An article featuring the lab that Dr. Amal led as a graduate student can be found here.
A YNET article about Dr. Amal's Lab (Hebrew) can be found here.